GB2311067B - Proline rich peptides derived from the rasgap-associated protein P62 - Google Patents

Proline rich peptides derived from the rasgap-associated protein P62

Info

Publication number
GB2311067B
GB2311067B GB9600307A GB9600307A GB2311067B GB 2311067 B GB2311067 B GB 2311067B GB 9600307 A GB9600307 A GB 9600307A GB 9600307 A GB9600307 A GB 9600307A GB 2311067 B GB2311067 B GB 2311067B
Authority
GB
United Kingdom
Prior art keywords
rasgap
associated protein
peptides derived
proline rich
rich peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9600307A
Other versions
GB2311067A (en
GB9600307D0 (en
Inventor
Peter Finan
Stuart Kellie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Yamanouchi UK Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi UK Ltd, Ludwig Institute for Cancer Research New York filed Critical Yamanouchi UK Ltd
Priority to GB9600307A priority Critical patent/GB2311067B/en
Publication of GB9600307D0 publication Critical patent/GB9600307D0/en
Publication of GB2311067A publication Critical patent/GB2311067A/en
Application granted granted Critical
Publication of GB2311067B publication Critical patent/GB2311067B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9600307A 1996-01-08 1996-01-08 Proline rich peptides derived from the rasgap-associated protein P62 Expired - Fee Related GB2311067B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9600307A GB2311067B (en) 1996-01-08 1996-01-08 Proline rich peptides derived from the rasgap-associated protein P62

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9600307A GB2311067B (en) 1996-01-08 1996-01-08 Proline rich peptides derived from the rasgap-associated protein P62

Publications (3)

Publication Number Publication Date
GB9600307D0 GB9600307D0 (en) 1996-03-13
GB2311067A GB2311067A (en) 1997-09-17
GB2311067B true GB2311067B (en) 2000-03-29

Family

ID=10786741

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9600307A Expired - Fee Related GB2311067B (en) 1996-01-08 1996-01-08 Proline rich peptides derived from the rasgap-associated protein P62

Country Status (1)

Country Link
GB (1) GB2311067B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020794A1 (en) * 1991-05-17 1992-11-26 Cetus Oncology Corporation Purification and cloning of p62
GB2285047A (en) * 1993-12-21 1995-06-28 Yamanouchi U K Ltd Polypeptides, rich in proline, which inhibit the NADPH oxidase system
WO1995024419A1 (en) * 1994-03-11 1995-09-14 Ariad Pharmaceuticals, Inc. Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020794A1 (en) * 1991-05-17 1992-11-26 Cetus Oncology Corporation Purification and cloning of p62
GB2285047A (en) * 1993-12-21 1995-06-28 Yamanouchi U K Ltd Polypeptides, rich in proline, which inhibit the NADPH oxidase system
WO1995024419A1 (en) * 1994-03-11 1995-09-14 Ariad Pharmaceuticals, Inc. Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cell 1992 69 (3) pgs 551-558 Wong et al. *

Also Published As

Publication number Publication date
GB2311067A (en) 1997-09-17
GB9600307D0 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
EP0907368A4 (en) Novel heparin binding peptides
NO985680L (en) peptide
HUP9900619A3 (en) Hybrid proteins which form heterodimers
GB9609702D0 (en) Anticoagulant peptides
ZA9710338B (en) Proteins
PL318017A1 (en) Peptides
GB9500601D0 (en) Modified peptides
NO983849L (en) peptide
EP0746565A4 (en) Novel bombesin-related peptides
AU1235597A (en) Fibrinogen binding peptides
GB9425380D0 (en) Peptides
GB9627114D0 (en) Multiple branch peptide constructions
GB9413316D0 (en) Novel proteins
GB2311067B (en) Proline rich peptides derived from the rasgap-associated protein P62
GB9613705D0 (en) Novel peptides
GB2311783B (en) Polypeptides derived from wasp protein
EP0915100A4 (en) Novel protein
GB9425381D0 (en) Peptides
SI0894141T1 (en) Hybrid proteins which form heterodimers
EP0888383A4 (en) Anti-inflammatory peptides derived from c-reactive protein
GB9604865D0 (en) Modified proteins
GB9605904D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9626362D0 (en) Peptides
GB9612648D0 (en) Peptides

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20020108